Establishment of core index database of China clinical trial energy efficiency index

Since the official launch of China clinical trial capability & efficiency index (hereinafter referred to as CTCE index) in June, after more than 100 days of research, discussion, analysis and revision by all members of the expert working committee, it has finally ushered in significant progress at a stage! On October 10, the second meeting of China clinical trial energy efficiency index expert working committee was jointly sponsored by the pharmaceutical clinical evaluation and research professional committee of China Pharmaceutical Association and huoshichuang Based on the work content of the first phase of the project, experts discussed and reached consensus on the selected indicators, data sources and collection methods one by one, and finally formed the core indicator database CTCE index is a data-driven index, which conducts systematic research and Analysis on clinical trial research capacity and efficiency, aiming to accelerate the efficiency of pharmaceutical innovation and drive the industry's self-improvement According to Xu Chongyuan, chairman of the pharmaceutical clinical evaluation and research professional committee of China Pharmaceutical Association and director of the drug clinical trial center of Southern Hospital of Southern Medical University, the determination of the core index database has a milestone significance for the final establishment of CTCE index, which will effectively promote the next step of the project to comprehensively determine the index weight and start the data collection In addition, the meeting carried out the work of updating experts of the expert working committee As of the date of the meeting, members of the expert working committee of CTCE index (drawn by surname as follows) include: Bai Hua, assistant director of Clinical Pharmacology Center of Peking Union Medical College Hospital, Cao Guoying, director of clinical trial Office of Huashan Hospital Affiliated to Fudan University, Cao Yu, director of national clinical trial Office of Affiliated Hospital of Qingdao University, Chen Yongchuan, director of institutional Office of the First Affiliated Hospital of Army Medical College (Southwest Hospital), deputy director of scientific research department of Shanghai First People's Hospital Jiang Yifeng, director of the ethics office, He Lin, deputy director of the pharmaceutical department (drug clinical trial center) of Sichuan Academy of Medical Sciences, Jiang Faye, director of the national drug clinical trial organization of Guangzhou people's Hospital, Lu Qi, director of the Ethics Committee Office of Shanghai Renji Hospital, Ruan zorong, director of the organization office of the Second Affiliated Hospital of Zhejiang University Medical College Shen Yifeng, director of institutional Office of Shanghai Mental Health Center, Tang Lei, director of institutional Office of the First Affiliated Hospital of Sun Yat sen University, deputy director of science and Technology Department of Jiangsu People's Hospital Wang Xiuqin, director of the office of the national drug clinical trial organization of the hospital, Wang MEIXIA, director of the national drug clinical trial organization of West China Hospital of Sichuan University, Wang Yongsheng, deputy director of the office of the national drug clinical trial organization of the Second Affiliated Hospital of Naval Military Medical University, Wei Hua, deputy director of the office of the national drug clinical trial organization of Shenzhen Second Hospital, Wu Jianlong, director of the organization office of Shenzhen Hospital of Peking University, Xu Fangzhou, director of the organization office of Shenzhen Hospital of Southern Medical University Director of clinical drug trial center Xu Chongyuan, Yang Hongying, deputy director of office of national drug clinical trial organization of Shenzhen People's Hospital, you Guangzhi, clinical trial center of Hong Kong University, yuan Wei'an, director of GCP center of Shuguang Hospital Affiliated to Shanghai University of traditional Chinese medicine, Zhao Min, director of Training Department of Chinese Journal of clinical pharmacology, Chinese Pharmaceutical Association, Institute of clinical pharmacology, Peking University, institutional Office of the first hospital affiliated to Zhejiang University Medical College Zhao Qingwei, director of the office, Diao Qingbo, huozegong, director of Hengrui pharmaceutical, Jiang Yangjun, director of clinical resource products of Huoshi creation, Dr Zhou Jun, vice president, Wang Hao, senior director of clinical resources of Bristol Myers Squibb, Wang Yun, senior director of science and pharmaceutical affairs of rdpac, Wu Yi, vice president of clinical and registration department of Huangpu Pharmaceutical (Shanghai), Shenzhen AoSA Pharmaceutical Research Institute Xing houxun, President, Xu Jiaqing, regional director of Bayer clinical trial operation, Yang Yu, manager of Guangdong dongyangguang Pharmaceutical Co., Ltd China clinical trial energy efficiency index officially launched